Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

CANNAPHARMARX, INC. (CPMD) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $0.02 Metrics
OS: 257.6 M
Market cap: $4.64 M
Net debt: $1.15 M
EV: $5.78 M

 
TTM Valuation
EBITDA
EBIT
EPS

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14
Revenues-6.70.00.00.00.00.00.00.0
            Revenue growth      -100.0% 
Cost of goods sold-6.70.00.00.00.01.011.70.0
Gross profit0.00.00.00.00.0-1.0-11.70.0
            Gross margin0.0%      89.9%
Selling, general and administrative   0.3   1.0
General and administrative2.13.11.10.00.00.34.20.8
EBITA-2.6-4.5-9.9-0.90.0-1.0-11.7-2.0
            EBITA margin39.2%      -5811.5%
Amortization of intangibles 0.10.1     
EBIT-2.6-4.6-10.1-0.90.0-1.0-11.7-2.0
            EBIT margin39.2%      -5811.5%
Pre-tax income-8.8-19.9-20.5-3.10.0-1.0-11.7-4.0
Income taxes0.00.00.00.00.00.00.00.0
            Tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income-8.8-19.9-20.5-3.10.0-1.0-11.7-4.0
            Net margin132.4%      -11428.7%
 
Diluted EPS($0.12)($0.49)($0.66)($0.17)$0.00($0.06)($0.77)($0.36)
Shares outstanding (diluted)74.740.731.218.018.018.015.311.1
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy